19 results
IDSA Suggested Empiric Antibiotic Regimens Based on Clinical Severity for Diabetic Foot Infections
Mild (usually treated with
IDSA Suggested Empiric ... Foot Infections ... #Foot #Infections ... #antibiotics #pharmacology ... #idsa #podiatry
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... (ER version) ... side effects (e.g ... Receptor #Agonists #Pharmacology ... #Summary #DM2 #diabetes
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... hypovolemia) • GU infections ... • Euglycemic diabetic ... SGLT2 #Inhibitors #Pharmacology ... #Summary #DM2 #diabetes
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Penicillium marneffei Infections ... amphotericin B, 3 to 5 mg/kg ... Penicilliosis #IDSA ... #HIVAIDS #pharmacology
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
Bydureon (Exenatide ER ... to treat Type 2 Diabetes ... GI tract) and injection ... GLP1 #Agonists #Pharmacology ... #Dosing #Diabetes
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... ., 4 mg/kg on days ... dose of 20–60 mg/kg ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA - Diabetic Foot Infections - Suggested Route, Setting, and Duration of Antibiotic Therapy, by Clinical
IDSA - Diabetic ... Foot Infections ... infected tissue (eg ... #Diabetic #Foot ... #antibiotics #pharmacology
Causes of Fatigue - Differential Diagnosis Algorithm
Endocrine
 • Hypo/Hyperthyroidism
 • Diabetes
 • Pituitary Insufficiency
 • Adrenal
Hyperthyroidism • Diabetes ... • Malignancy Infectious ... Myasthenia Gravis Pharmacologic ... • Drug Abuse (e.g
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Nifurtimox 8–10 mg/kg ... Trypanosomiasis #IDSA ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... amphotericin B 3–5 mg/kg ... deoxycholate 0.7–1.0 mg/kg ... Coccidiodomycosis #IDSA ... #HIVAIDS #pharmacology